Investor Update

Basel, 24 May 2013

Launch of Subcutaneous Injection formulation, Actemra, for treatment of Rheumatoid Arthritis in Japan

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.